We found that BAFFR is the most predominant aberrantly expressed receptor in B-ALL and that its expression, along with BCMA and APRIL, positively correlates with the maturation stage of B-lymphoblasts. The gene discussed is TNFRSF17; the disease is precursor B-cell acute lymphoblastic leukemia.